Ingalls & Snyder LLC Corcept Therapeutics Inc Call Options Transaction History

Ingalls & Snyder LLC

  • $2.56 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$29.51 - $46.26 $103,285 - $161,910
3,500 Added 43.75%
11,500 $532,000
Q2 2024

Jul 31, 2024
BUY
$22.21 - $34.48 $144,365 - $224,119
6,500 Added 433.33%
8,000 $260,000
Q1 2024

May 13, 2024
BUY
$21.1 - $27.46 $31,650 - $41,190
1,500 New
1,500 $38,000
Q3 2018

Oct 24, 2018
BUY
$12.27 - $15.65 $245,400 - $313,000
20,000 New
20,000 $280,000

Others Institutions Holding CORT

# of Institutions
347
Shares Held
86.6M
Call Options Held
1.12M
Put Options Held
667K
View Full List

About CORCEPT THERAPEUTICS INC

CORT Quotes by TradingView
  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $5.94B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Ingalls & Snyder LLC Portfolio

Follow Ingalls & Snyder LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ingalls & Snyder LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ingalls & Snyder LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email